10x Genomics, Inc.
TXG
Jodie situation report
10x Genomics, Inc.'s current read is isolated; its market group is not confirming.
No new filing conclusion is available. 0 of 9 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 2 directly disclosed connections are confirming.
- TXG's market-adjusted activity becomes unusual and at least one connected name confirms.
Invalidation: The isolated read changes if TXG's group or a disclosed connection begins moving with it.
Who this business touches
The relationships behind TXG
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
BRKRBruker CorporationpartnerMay 8, 2026 ▾
“In 2025, we entered into a settlement agreement and license agreements with Bruker under which we will receive four quarterly installment payments totaling $68.0 million beginning in the third quarter of 2025 with applicable interest.”
Depended on by
BRKRBruker CorporationcompetitorFeb 27, 2026 ▾
“BSI NANO The BSI NANO Segment competes with companies that offer analytical X-ray solutions, OES systems, AFM and SOM systems, optical fluorescence systems, and genomics tools, primarily Rigaku, Oxford Instruments, Agilent, Thermo Fisher Scientific, Ametek’s…”
Filing peers
Companies whose filings use similar operating language.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 6 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
TXG is currently a Follower in the organic co-movement group Speculative Growth. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 2 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.